nodes	percent_of_prediction	percent_of_DWPC	metapath
Azelastine—Cloperastine—Raloxifene—osteoporosis	0.333	1	CrCrCtD
Azelastine—CYP1A1—Cholecalciferol—osteoporosis	0.0307	0.0643	CbGbCtD
Azelastine—CYP2B6—Raloxifene—osteoporosis	0.0303	0.0634	CbGbCtD
Azelastine—CYP2B6—Ethinyl Estradiol—osteoporosis	0.0292	0.0613	CbGbCtD
Azelastine—CYP1A2—Estropipate—osteoporosis	0.0266	0.0557	CbGbCtD
Azelastine—CYP1A1—Estradiol—osteoporosis	0.0247	0.0518	CbGbCtD
Azelastine—CYP2C9—Estropipate—osteoporosis	0.024	0.0502	CbGbCtD
Azelastine—CYP2B6—Cholecalciferol—osteoporosis	0.0234	0.049	CbGbCtD
Azelastine—CYP2C8—Raloxifene—osteoporosis	0.0229	0.048	CbGbCtD
Azelastine—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0221	0.0464	CbGbCtD
Azelastine—CYP2C8—Cholecalciferol—osteoporosis	0.0177	0.0371	CbGbCtD
Azelastine—ABCB1—Ethinyl Estradiol—osteoporosis	0.015	0.0314	CbGbCtD
Azelastine—CYP2C19—Cholecalciferol—osteoporosis	0.0149	0.0311	CbGbCtD
Azelastine—CYP3A5—Estradiol—osteoporosis	0.0148	0.0311	CbGbCtD
Azelastine—CYP2C8—Estradiol—osteoporosis	0.0143	0.0299	CbGbCtD
Azelastine—CYP3A4—Estropipate—osteoporosis	0.0139	0.0292	CbGbCtD
Azelastine—CYP3A4—Calcitriol—osteoporosis	0.0139	0.0292	CbGbCtD
Azelastine—CYP1A2—Conjugated Estrogens—osteoporosis	0.0126	0.0264	CbGbCtD
Azelastine—CYP2C9—Cholecalciferol—osteoporosis	0.0123	0.0259	CbGbCtD
Azelastine—CYP2C19—Estradiol—osteoporosis	0.012	0.0251	CbGbCtD
Azelastine—CYP2D6—Cholecalciferol—osteoporosis	0.0113	0.0237	CbGbCtD
Azelastine—CYP3A4—Ergocalciferol—osteoporosis	0.0111	0.0233	CbGbCtD
Azelastine—CYP1A2—Estradiol—osteoporosis	0.011	0.0231	CbGbCtD
Azelastine—ABCB1—Conjugated Estrogens—osteoporosis	0.011	0.0231	CbGbCtD
Azelastine—CYP2C9—Estradiol—osteoporosis	0.00995	0.0209	CbGbCtD
Azelastine—ABCB1—Estradiol—osteoporosis	0.00966	0.0202	CbGbCtD
Azelastine—CYP3A4—Raloxifene—osteoporosis	0.0093	0.0195	CbGbCtD
Azelastine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.00898	0.0188	CbGbCtD
Azelastine—CYP3A4—Cholecalciferol—osteoporosis	0.00718	0.015	CbGbCtD
Azelastine—CYP3A4—Conjugated Estrogens—osteoporosis	0.00659	0.0138	CbGbCtD
Azelastine—CYP3A4—Estradiol—osteoporosis	0.00579	0.0121	CbGbCtD
Azelastine—Vision blurred—Zoledronate—osteoporosis	0.000218	0.00139	CcSEcCtD
Azelastine—Gastrointestinal pain—Raloxifene—osteoporosis	0.000218	0.00139	CcSEcCtD
Azelastine—Diarrhoea—Etidronic acid—osteoporosis	0.000218	0.00139	CcSEcCtD
Azelastine—Haematuria—Estradiol—osteoporosis	0.000218	0.00139	CcSEcCtD
Azelastine—Abdominal pain—Estropipate—osteoporosis	0.000218	0.00139	CcSEcCtD
Azelastine—Body temperature increased—Estropipate—osteoporosis	0.000218	0.00139	CcSEcCtD
Azelastine—Feeling abnormal—Ibandronate—osteoporosis	0.000217	0.00139	CcSEcCtD
Azelastine—Nervousness—Conjugated Estrogens—osteoporosis	0.000216	0.00138	CcSEcCtD
Azelastine—Infection—Risedronate—osteoporosis	0.000216	0.00138	CcSEcCtD
Azelastine—Gastrointestinal pain—Ibandronate—osteoporosis	0.000216	0.00138	CcSEcCtD
Azelastine—Myalgia—Pamidronate—osteoporosis	0.000216	0.00138	CcSEcCtD
Azelastine—Back pain—Conjugated Estrogens—osteoporosis	0.000216	0.00138	CcSEcCtD
Azelastine—Epistaxis—Estradiol—osteoporosis	0.000215	0.00137	CcSEcCtD
Azelastine—Anxiety—Pamidronate—osteoporosis	0.000215	0.00137	CcSEcCtD
Azelastine—Ill-defined disorder—Zoledronate—osteoporosis	0.000215	0.00137	CcSEcCtD
Azelastine—Body temperature increased—Alendronate—osteoporosis	0.000214	0.00137	CcSEcCtD
Azelastine—Abdominal pain—Alendronate—osteoporosis	0.000214	0.00137	CcSEcCtD
Azelastine—Sinusitis—Estradiol—osteoporosis	0.000214	0.00137	CcSEcCtD
Azelastine—Discomfort—Pamidronate—osteoporosis	0.000213	0.00136	CcSEcCtD
Azelastine—Agitation—Zoledronate—osteoporosis	0.000213	0.00136	CcSEcCtD
Azelastine—Gastrointestinal pain—Calcitriol—osteoporosis	0.000211	0.00135	CcSEcCtD
Azelastine—Abdominal pain—Raloxifene—osteoporosis	0.000211	0.00134	CcSEcCtD
Azelastine—Body temperature increased—Raloxifene—osteoporosis	0.000211	0.00134	CcSEcCtD
Azelastine—Vision blurred—Conjugated Estrogens—osteoporosis	0.00021	0.00134	CcSEcCtD
Azelastine—Malaise—Zoledronate—osteoporosis	0.000209	0.00133	CcSEcCtD
Azelastine—Abdominal pain—Ibandronate—osteoporosis	0.000209	0.00133	CcSEcCtD
Azelastine—Body temperature increased—Ibandronate—osteoporosis	0.000209	0.00133	CcSEcCtD
Azelastine—Confusional state—Pamidronate—osteoporosis	0.000208	0.00133	CcSEcCtD
Azelastine—Vertigo—Zoledronate—osteoporosis	0.000208	0.00133	CcSEcCtD
Azelastine—Anaphylactic shock—Pamidronate—osteoporosis	0.000207	0.00132	CcSEcCtD
Azelastine—Infection—Pamidronate—osteoporosis	0.000205	0.00131	CcSEcCtD
Azelastine—Rhinitis—Estradiol—osteoporosis	0.000205	0.00131	CcSEcCtD
Azelastine—Palpitations—Zoledronate—osteoporosis	0.000204	0.0013	CcSEcCtD
Azelastine—Abdominal pain—Calcitriol—osteoporosis	0.000204	0.0013	CcSEcCtD
Azelastine—Body temperature increased—Calcitriol—osteoporosis	0.000204	0.0013	CcSEcCtD
Azelastine—Hypoaesthesia—Estradiol—osteoporosis	0.000204	0.0013	CcSEcCtD
Azelastine—Pharyngitis—Estradiol—osteoporosis	0.000203	0.0013	CcSEcCtD
Azelastine—Hypersensitivity—Estropipate—osteoporosis	0.000203	0.00129	CcSEcCtD
Azelastine—Vomiting—Etidronic acid—osteoporosis	0.000202	0.00129	CcSEcCtD
Azelastine—Cough—Zoledronate—osteoporosis	0.000202	0.00129	CcSEcCtD
Azelastine—Tachycardia—Pamidronate—osteoporosis	0.000202	0.00129	CcSEcCtD
Azelastine—Rash—Etidronic acid—osteoporosis	0.000201	0.00128	CcSEcCtD
Azelastine—Dermatitis—Etidronic acid—osteoporosis	0.0002	0.00128	CcSEcCtD
Azelastine—Vertigo—Conjugated Estrogens—osteoporosis	0.0002	0.00128	CcSEcCtD
Azelastine—Hypertension—Zoledronate—osteoporosis	0.0002	0.00127	CcSEcCtD
Azelastine—Hypersensitivity—Alendronate—osteoporosis	0.0002	0.00127	CcSEcCtD
Azelastine—Headache—Etidronic acid—osteoporosis	0.000199	0.00127	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000198	0.00126	CcSEcCtD
Azelastine—Asthenia—Estropipate—osteoporosis	0.000197	0.00126	CcSEcCtD
Azelastine—Visual impairment—Estradiol—osteoporosis	0.000197	0.00126	CcSEcCtD
Azelastine—Myalgia—Zoledronate—osteoporosis	0.000197	0.00126	CcSEcCtD
Azelastine—Chest pain—Zoledronate—osteoporosis	0.000197	0.00126	CcSEcCtD
Azelastine—Palpitations—Conjugated Estrogens—osteoporosis	0.000197	0.00126	CcSEcCtD
Azelastine—Anxiety—Zoledronate—osteoporosis	0.000196	0.00125	CcSEcCtD
Azelastine—Paraesthesia—Risedronate—osteoporosis	0.000195	0.00125	CcSEcCtD
Azelastine—Pruritus—Estropipate—osteoporosis	0.000195	0.00124	CcSEcCtD
Azelastine—Discomfort—Zoledronate—osteoporosis	0.000195	0.00124	CcSEcCtD
Azelastine—Asthenia—Alendronate—osteoporosis	0.000194	0.00124	CcSEcCtD
Azelastine—Hypersensitivity—Ibandronate—osteoporosis	0.000194	0.00124	CcSEcCtD
Azelastine—Cough—Conjugated Estrogens—osteoporosis	0.000194	0.00124	CcSEcCtD
Azelastine—Dyspnoea—Risedronate—osteoporosis	0.000194	0.00124	CcSEcCtD
Azelastine—Dry mouth—Zoledronate—osteoporosis	0.000193	0.00123	CcSEcCtD
Azelastine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000192	0.00123	CcSEcCtD
Azelastine—Pruritus—Alendronate—osteoporosis	0.000192	0.00122	CcSEcCtD
Azelastine—Eye disorder—Estradiol—osteoporosis	0.000191	0.00122	CcSEcCtD
Azelastine—Constipation—Ethinyl Estradiol—osteoporosis	0.000191	0.00122	CcSEcCtD
Azelastine—Confusional state—Zoledronate—osteoporosis	0.00019	0.00121	CcSEcCtD
Azelastine—Hypersensitivity—Calcitriol—osteoporosis	0.00019	0.00121	CcSEcCtD
Azelastine—Flushing—Estradiol—osteoporosis	0.00019	0.00121	CcSEcCtD
Azelastine—Chest pain—Conjugated Estrogens—osteoporosis	0.00019	0.00121	CcSEcCtD
Azelastine—Myalgia—Conjugated Estrogens—osteoporosis	0.00019	0.00121	CcSEcCtD
Azelastine—Asthenia—Ibandronate—osteoporosis	0.000189	0.00121	CcSEcCtD
Azelastine—Anxiety—Conjugated Estrogens—osteoporosis	0.000189	0.00121	CcSEcCtD
Azelastine—Nausea—Etidronic acid—osteoporosis	0.000189	0.00121	CcSEcCtD
Azelastine—Anaphylactic shock—Zoledronate—osteoporosis	0.000189	0.0012	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000188	0.0012	CcSEcCtD
Azelastine—Diarrhoea—Estropipate—osteoporosis	0.000188	0.0012	CcSEcCtD
Azelastine—Infection—Zoledronate—osteoporosis	0.000188	0.0012	CcSEcCtD
Azelastine—Fatigue—Risedronate—osteoporosis	0.000188	0.0012	CcSEcCtD
Azelastine—Pruritus—Ibandronate—osteoporosis	0.000187	0.00119	CcSEcCtD
Azelastine—Constipation—Risedronate—osteoporosis	0.000186	0.00119	CcSEcCtD
Azelastine—Pain—Risedronate—osteoporosis	0.000186	0.00119	CcSEcCtD
Azelastine—Paraesthesia—Pamidronate—osteoporosis	0.000186	0.00118	CcSEcCtD
Azelastine—Diarrhoea—Alendronate—osteoporosis	0.000185	0.00118	CcSEcCtD
Azelastine—Asthenia—Calcitriol—osteoporosis	0.000185	0.00118	CcSEcCtD
Azelastine—Dyspnoea—Pamidronate—osteoporosis	0.000184	0.00118	CcSEcCtD
Azelastine—Tachycardia—Zoledronate—osteoporosis	0.000184	0.00118	CcSEcCtD
Azelastine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000184	0.00117	CcSEcCtD
Azelastine—Somnolence—Pamidronate—osteoporosis	0.000184	0.00117	CcSEcCtD
Azelastine—Pruritus—Calcitriol—osteoporosis	0.000183	0.00117	CcSEcCtD
Azelastine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000182	0.00116	CcSEcCtD
Azelastine—Diarrhoea—Raloxifene—osteoporosis	0.000182	0.00116	CcSEcCtD
Azelastine—Dizziness—Estropipate—osteoporosis	0.000182	0.00116	CcSEcCtD
Azelastine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000182	0.00116	CcSEcCtD
Azelastine—Infection—Conjugated Estrogens—osteoporosis	0.000181	0.00115	CcSEcCtD
Azelastine—Diarrhoea—Ibandronate—osteoporosis	0.000181	0.00115	CcSEcCtD
Azelastine—Dizziness—Alendronate—osteoporosis	0.000179	0.00114	CcSEcCtD
Azelastine—Fatigue—Pamidronate—osteoporosis	0.000178	0.00114	CcSEcCtD
Azelastine—Gastrointestinal pain—Risedronate—osteoporosis	0.000178	0.00113	CcSEcCtD
Azelastine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000177	0.00113	CcSEcCtD
Azelastine—Constipation—Pamidronate—osteoporosis	0.000177	0.00113	CcSEcCtD
Azelastine—Pain—Pamidronate—osteoporosis	0.000177	0.00113	CcSEcCtD
Azelastine—Diarrhoea—Calcitriol—osteoporosis	0.000177	0.00113	CcSEcCtD
Azelastine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000176	0.00113	CcSEcCtD
Azelastine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000176	0.00113	CcSEcCtD
Azelastine—Dizziness—Raloxifene—osteoporosis	0.000176	0.00112	CcSEcCtD
Azelastine—Tension—Estradiol—osteoporosis	0.000175	0.00112	CcSEcCtD
Azelastine—Vomiting—Estropipate—osteoporosis	0.000175	0.00112	CcSEcCtD
Azelastine—Dysgeusia—Estradiol—osteoporosis	0.000175	0.00111	CcSEcCtD
Azelastine—Dizziness—Ibandronate—osteoporosis	0.000175	0.00111	CcSEcCtD
Azelastine—Rash—Estropipate—osteoporosis	0.000174	0.00111	CcSEcCtD
Azelastine—Dermatitis—Estropipate—osteoporosis	0.000173	0.00111	CcSEcCtD
Azelastine—Nervousness—Estradiol—osteoporosis	0.000173	0.00111	CcSEcCtD
Azelastine—Back pain—Estradiol—osteoporosis	0.000172	0.0011	CcSEcCtD
Azelastine—Headache—Estropipate—osteoporosis	0.000172	0.0011	CcSEcCtD
Azelastine—Vomiting—Alendronate—osteoporosis	0.000172	0.0011	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000172	0.0011	CcSEcCtD
Azelastine—Abdominal pain—Risedronate—osteoporosis	0.000172	0.0011	CcSEcCtD
Azelastine—Body temperature increased—Risedronate—osteoporosis	0.000172	0.0011	CcSEcCtD
Azelastine—Rash—Alendronate—osteoporosis	0.000171	0.00109	CcSEcCtD
Azelastine—Dermatitis—Alendronate—osteoporosis	0.000171	0.00109	CcSEcCtD
Azelastine—Feeling abnormal—Pamidronate—osteoporosis	0.00017	0.00109	CcSEcCtD
Azelastine—Headache—Alendronate—osteoporosis	0.00017	0.00108	CcSEcCtD
Azelastine—Paraesthesia—Zoledronate—osteoporosis	0.00017	0.00108	CcSEcCtD
Azelastine—Vomiting—Raloxifene—osteoporosis	0.000169	0.00108	CcSEcCtD
Azelastine—Gastrointestinal pain—Pamidronate—osteoporosis	0.000169	0.00108	CcSEcCtD
Azelastine—Dyspnoea—Zoledronate—osteoporosis	0.000168	0.00107	CcSEcCtD
Azelastine—Rash—Raloxifene—osteoporosis	0.000168	0.00107	CcSEcCtD
Azelastine—Dermatitis—Raloxifene—osteoporosis	0.000168	0.00107	CcSEcCtD
Azelastine—Somnolence—Zoledronate—osteoporosis	0.000168	0.00107	CcSEcCtD
Azelastine—Vomiting—Ibandronate—osteoporosis	0.000168	0.00107	CcSEcCtD
Azelastine—Headache—Raloxifene—osteoporosis	0.000167	0.00107	CcSEcCtD
Azelastine—Rash—Ibandronate—osteoporosis	0.000166	0.00106	CcSEcCtD
Azelastine—Dermatitis—Ibandronate—osteoporosis	0.000166	0.00106	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000166	0.00106	CcSEcCtD
Azelastine—Ill-defined disorder—Estradiol—osteoporosis	0.000165	0.00106	CcSEcCtD
Azelastine—Headache—Ibandronate—osteoporosis	0.000165	0.00105	CcSEcCtD
Azelastine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000164	0.00105	CcSEcCtD
Azelastine—Vomiting—Calcitriol—osteoporosis	0.000164	0.00105	CcSEcCtD
Azelastine—Agitation—Estradiol—osteoporosis	0.000164	0.00105	CcSEcCtD
Azelastine—Nausea—Estropipate—osteoporosis	0.000163	0.00104	CcSEcCtD
Azelastine—Body temperature increased—Pamidronate—osteoporosis	0.000163	0.00104	CcSEcCtD
Azelastine—Abdominal pain—Pamidronate—osteoporosis	0.000163	0.00104	CcSEcCtD
Azelastine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000163	0.00104	CcSEcCtD
Azelastine—Rash—Calcitriol—osteoporosis	0.000163	0.00104	CcSEcCtD
Azelastine—Fatigue—Zoledronate—osteoporosis	0.000163	0.00104	CcSEcCtD
Azelastine—Dermatitis—Calcitriol—osteoporosis	0.000163	0.00104	CcSEcCtD
Azelastine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000162	0.00103	CcSEcCtD
Azelastine—Headache—Calcitriol—osteoporosis	0.000162	0.00103	CcSEcCtD
Azelastine—Somnolence—Conjugated Estrogens—osteoporosis	0.000162	0.00103	CcSEcCtD
Azelastine—Constipation—Zoledronate—osteoporosis	0.000161	0.00103	CcSEcCtD
Azelastine—Pain—Zoledronate—osteoporosis	0.000161	0.00103	CcSEcCtD
Azelastine—Nausea—Alendronate—osteoporosis	0.000161	0.00103	CcSEcCtD
Azelastine—Malaise—Estradiol—osteoporosis	0.000161	0.00103	CcSEcCtD
Azelastine—Hypersensitivity—Risedronate—osteoporosis	0.00016	0.00102	CcSEcCtD
Azelastine—Vertigo—Estradiol—osteoporosis	0.00016	0.00102	CcSEcCtD
Azelastine—Asthenia—Ethinyl Estradiol—osteoporosis	0.00016	0.00102	CcSEcCtD
Azelastine—Nausea—Raloxifene—osteoporosis	0.000158	0.00101	CcSEcCtD
Azelastine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000158	0.00101	CcSEcCtD
Azelastine—Palpitations—Estradiol—osteoporosis	0.000158	0.00101	CcSEcCtD
Azelastine—Fatigue—Conjugated Estrogens—osteoporosis	0.000157	0.001	CcSEcCtD
Azelastine—Nausea—Ibandronate—osteoporosis	0.000157	0.001	CcSEcCtD
Azelastine—Asthenia—Risedronate—osteoporosis	0.000156	0.000996	CcSEcCtD
Azelastine—Feeling abnormal—Zoledronate—osteoporosis	0.000156	0.000993	CcSEcCtD
Azelastine—Cough—Estradiol—osteoporosis	0.000156	0.000993	CcSEcCtD
Azelastine—Constipation—Conjugated Estrogens—osteoporosis	0.000155	0.000992	CcSEcCtD
Azelastine—Pain—Conjugated Estrogens—osteoporosis	0.000155	0.000992	CcSEcCtD
Azelastine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000154	0.000985	CcSEcCtD
Azelastine—Hypertension—Estradiol—osteoporosis	0.000154	0.000982	CcSEcCtD
Azelastine—Pruritus—Risedronate—osteoporosis	0.000154	0.000982	CcSEcCtD
Azelastine—Nausea—Calcitriol—osteoporosis	0.000153	0.000979	CcSEcCtD
Azelastine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000153	0.000974	CcSEcCtD
Azelastine—Hypersensitivity—Pamidronate—osteoporosis	0.000152	0.000972	CcSEcCtD
Azelastine—Chest pain—Estradiol—osteoporosis	0.000152	0.000969	CcSEcCtD
Azelastine—Myalgia—Estradiol—osteoporosis	0.000152	0.000969	CcSEcCtD
Azelastine—Anxiety—Estradiol—osteoporosis	0.000151	0.000965	CcSEcCtD
Azelastine—Discomfort—Estradiol—osteoporosis	0.00015	0.000957	CcSEcCtD
Azelastine—Abdominal pain—Zoledronate—osteoporosis	0.000149	0.000953	CcSEcCtD
Azelastine—Body temperature increased—Zoledronate—osteoporosis	0.000149	0.000953	CcSEcCtD
Azelastine—Diarrhoea—Risedronate—osteoporosis	0.000149	0.000949	CcSEcCtD
Azelastine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000149	0.000949	CcSEcCtD
Azelastine—Dry mouth—Estradiol—osteoporosis	0.000148	0.000947	CcSEcCtD
Azelastine—Asthenia—Pamidronate—osteoporosis	0.000148	0.000946	CcSEcCtD
Azelastine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000148	0.000941	CcSEcCtD
Azelastine—Confusional state—Estradiol—osteoporosis	0.000147	0.000936	CcSEcCtD
Azelastine—Pruritus—Pamidronate—osteoporosis	0.000146	0.000933	CcSEcCtD
Azelastine—Anaphylactic shock—Estradiol—osteoporosis	0.000146	0.000929	CcSEcCtD
Azelastine—Infection—Estradiol—osteoporosis	0.000145	0.000922	CcSEcCtD
Azelastine—Dizziness—Risedronate—osteoporosis	0.000144	0.000918	CcSEcCtD
Azelastine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000144	0.000917	CcSEcCtD
Azelastine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000144	0.000917	CcSEcCtD
Azelastine—Tachycardia—Estradiol—osteoporosis	0.000142	0.000906	CcSEcCtD
Azelastine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000142	0.000905	CcSEcCtD
Azelastine—Diarrhoea—Pamidronate—osteoporosis	0.000141	0.000903	CcSEcCtD
Azelastine—Rash—Ethinyl Estradiol—osteoporosis	0.000141	0.000897	CcSEcCtD
Azelastine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000141	0.000897	CcSEcCtD
Azelastine—Headache—Ethinyl Estradiol—osteoporosis	0.00014	0.000892	CcSEcCtD
Azelastine—Hypersensitivity—Zoledronate—osteoporosis	0.000139	0.000888	CcSEcCtD
Azelastine—Vomiting—Risedronate—osteoporosis	0.000138	0.000882	CcSEcCtD
Azelastine—Rash—Risedronate—osteoporosis	0.000137	0.000875	CcSEcCtD
Azelastine—Dermatitis—Risedronate—osteoporosis	0.000137	0.000874	CcSEcCtD
Azelastine—Dizziness—Pamidronate—osteoporosis	0.000137	0.000872	CcSEcCtD
Azelastine—Headache—Risedronate—osteoporosis	0.000136	0.000869	CcSEcCtD
Azelastine—Asthenia—Zoledronate—osteoporosis	0.000135	0.000864	CcSEcCtD
Azelastine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000134	0.000855	CcSEcCtD
Azelastine—Pruritus—Zoledronate—osteoporosis	0.000134	0.000852	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000133	0.000846	CcSEcCtD
Azelastine—Nausea—Ethinyl Estradiol—osteoporosis	0.000132	0.000845	CcSEcCtD
Azelastine—Vomiting—Pamidronate—osteoporosis	0.000131	0.000839	CcSEcCtD
Azelastine—Paraesthesia—Estradiol—osteoporosis	0.000131	0.000834	CcSEcCtD
Azelastine—Asthenia—Conjugated Estrogens—osteoporosis	0.00013	0.000832	CcSEcCtD
Azelastine—Rash—Pamidronate—osteoporosis	0.00013	0.000832	CcSEcCtD
Azelastine—Dermatitis—Pamidronate—osteoporosis	0.00013	0.000831	CcSEcCtD
Azelastine—Dyspnoea—Estradiol—osteoporosis	0.00013	0.000828	CcSEcCtD
Azelastine—Headache—Pamidronate—osteoporosis	0.00013	0.000826	CcSEcCtD
Azelastine—Somnolence—Estradiol—osteoporosis	0.000129	0.000825	CcSEcCtD
Azelastine—Diarrhoea—Zoledronate—osteoporosis	0.000129	0.000824	CcSEcCtD
Azelastine—Nausea—Risedronate—osteoporosis	0.000129	0.000824	CcSEcCtD
Azelastine—Pruritus—Conjugated Estrogens—osteoporosis	0.000129	0.000821	CcSEcCtD
Azelastine—Fatigue—Estradiol—osteoporosis	0.000125	0.000801	CcSEcCtD
Azelastine—Dizziness—Zoledronate—osteoporosis	0.000125	0.000797	CcSEcCtD
Azelastine—Pain—Estradiol—osteoporosis	0.000124	0.000794	CcSEcCtD
Azelastine—Constipation—Estradiol—osteoporosis	0.000124	0.000794	CcSEcCtD
Azelastine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000124	0.000794	CcSEcCtD
Azelastine—Nausea—Pamidronate—osteoporosis	0.000123	0.000784	CcSEcCtD
Azelastine—Dizziness—Conjugated Estrogens—osteoporosis	0.00012	0.000767	CcSEcCtD
Azelastine—Vomiting—Zoledronate—osteoporosis	0.00012	0.000766	CcSEcCtD
Azelastine—Feeling abnormal—Estradiol—osteoporosis	0.00012	0.000765	CcSEcCtD
Azelastine—Rash—Zoledronate—osteoporosis	0.000119	0.00076	CcSEcCtD
Azelastine—Gastrointestinal pain—Estradiol—osteoporosis	0.000119	0.000759	CcSEcCtD
Azelastine—Dermatitis—Zoledronate—osteoporosis	0.000119	0.000759	CcSEcCtD
Azelastine—Headache—Zoledronate—osteoporosis	0.000118	0.000755	CcSEcCtD
Azelastine—Vomiting—Conjugated Estrogens—osteoporosis	0.000116	0.000738	CcSEcCtD
Azelastine—Body temperature increased—Estradiol—osteoporosis	0.000115	0.000734	CcSEcCtD
Azelastine—Abdominal pain—Estradiol—osteoporosis	0.000115	0.000734	CcSEcCtD
Azelastine—Rash—Conjugated Estrogens—osteoporosis	0.000115	0.000732	CcSEcCtD
Azelastine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000115	0.000731	CcSEcCtD
Azelastine—Headache—Conjugated Estrogens—osteoporosis	0.000114	0.000727	CcSEcCtD
Azelastine—Nausea—Zoledronate—osteoporosis	0.000112	0.000716	CcSEcCtD
Azelastine—Nausea—Conjugated Estrogens—osteoporosis	0.000108	0.000689	CcSEcCtD
Azelastine—Hypersensitivity—Estradiol—osteoporosis	0.000107	0.000684	CcSEcCtD
Azelastine—Asthenia—Estradiol—osteoporosis	0.000104	0.000666	CcSEcCtD
Azelastine—Pruritus—Estradiol—osteoporosis	0.000103	0.000657	CcSEcCtD
Azelastine—Diarrhoea—Estradiol—osteoporosis	9.96e-05	0.000635	CcSEcCtD
Azelastine—Dizziness—Estradiol—osteoporosis	9.62e-05	0.000614	CcSEcCtD
Azelastine—Vomiting—Estradiol—osteoporosis	9.25e-05	0.00059	CcSEcCtD
Azelastine—Rash—Estradiol—osteoporosis	9.18e-05	0.000585	CcSEcCtD
Azelastine—Dermatitis—Estradiol—osteoporosis	9.17e-05	0.000585	CcSEcCtD
Azelastine—Headache—Estradiol—osteoporosis	9.12e-05	0.000582	CcSEcCtD
Azelastine—Nausea—Estradiol—osteoporosis	8.64e-05	0.000552	CcSEcCtD
Azelastine—CYP2B6—Metabolism—P4HB—osteoporosis	1.29e-05	0.000387	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—DKK1—osteoporosis	1.29e-05	0.000387	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—CYP27A1—osteoporosis	1.29e-05	0.000385	CbGpPWpGaD
Azelastine—CYP3A4—Biological oxidations—POMC—osteoporosis	1.28e-05	0.000382	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—TPI1—osteoporosis	1.27e-05	0.00038	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—GAPDH—osteoporosis	1.27e-05	0.00038	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—P4HB—osteoporosis	1.27e-05	0.000379	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—P4HB—osteoporosis	1.27e-05	0.000379	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—P4HB—osteoporosis	1.26e-05	0.000378	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—ACP5—osteoporosis	1.25e-05	0.000375	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—WNT1—osteoporosis	1.25e-05	0.000373	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—GAPDH—osteoporosis	1.24e-05	0.000372	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—GAPDH—osteoporosis	1.24e-05	0.000371	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—ENO1—osteoporosis	1.24e-05	0.000371	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.24e-05	0.00037	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—RAP1A—osteoporosis	1.24e-05	0.00037	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.24e-05	0.00037	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PTH—osteoporosis	1.23e-05	0.000368	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—IDH2—osteoporosis	1.22e-05	0.000366	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—PSMA2—osteoporosis	1.22e-05	0.000365	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—PSMA5—osteoporosis	1.22e-05	0.000365	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—FGA—osteoporosis	1.21e-05	0.000363	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—RAP1A—osteoporosis	1.21e-05	0.000362	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—RAP1A—osteoporosis	1.21e-05	0.000362	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—RAP1A—osteoporosis	1.21e-05	0.000362	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PKM—osteoporosis	1.2e-05	0.00036	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—FDPS—osteoporosis	1.2e-05	0.00036	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CNR2—osteoporosis	1.2e-05	0.000359	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—P4HB—osteoporosis	1.2e-05	0.000357	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—ADCY5—osteoporosis	1.2e-05	0.000357	CbGpPWpGaD
Azelastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	1.19e-05	0.000357	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—IDH2—osteoporosis	1.19e-05	0.000357	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—ADCY5—osteoporosis	1.19e-05	0.000356	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—NFATC1—osteoporosis	1.18e-05	0.000353	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—GAPDH—osteoporosis	1.17e-05	0.000351	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—DKK1—osteoporosis	1.17e-05	0.00035	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—TPI1—osteoporosis	1.17e-05	0.000348	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CA2—osteoporosis	1.15e-05	0.000344	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—OXCT1—osteoporosis	1.15e-05	0.000344	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—CYP27A1—osteoporosis	1.15e-05	0.000344	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—RAP1A—osteoporosis	1.14e-05	0.000342	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PGLS—osteoporosis	1.14e-05	0.000341	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—GPD2—osteoporosis	1.14e-05	0.000341	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—WNT1—osteoporosis	1.13e-05	0.000337	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PTHLH—osteoporosis	1.13e-05	0.000337	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—BMP2—osteoporosis	1.13e-05	0.000337	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—IDH2—osteoporosis	1.13e-05	0.000336	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—CYP27A1—osteoporosis	1.12e-05	0.000336	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—MGLL—osteoporosis	1.12e-05	0.000335	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—ACP5—osteoporosis	1.12e-05	0.000335	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—IDH2—osteoporosis	1.12e-05	0.000334	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.1e-05	0.00033	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—FGB—osteoporosis	1.1e-05	0.00033	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.1e-05	0.000329	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.1e-05	0.000329	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—FGA—osteoporosis	1.1e-05	0.000328	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—P4HB—osteoporosis	1.1e-05	0.000328	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—ACP5—osteoporosis	1.09e-05	0.000327	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—ADCY5—osteoporosis	1.08e-05	0.000323	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—GAPDH—osteoporosis	1.08e-05	0.000322	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PSMA2—osteoporosis	1.06e-05	0.000318	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PSMA5—osteoporosis	1.06e-05	0.000318	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—CYP27A1—osteoporosis	1.06e-05	0.000316	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.06e-05	0.000316	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CYP27A1—osteoporosis	1.05e-05	0.000314	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—RAP1A—osteoporosis	1.05e-05	0.000313	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—IL6—osteoporosis	1.05e-05	0.000313	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ATIC—osteoporosis	1.04e-05	0.000312	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PNP—osteoporosis	1.04e-05	0.000312	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—TPI1—osteoporosis	1.04e-05	0.000311	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—ACP5—osteoporosis	1.03e-05	0.000308	CbGpPWpGaD
Azelastine—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.03e-05	0.000308	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.03e-05	0.000307	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PTHLH—osteoporosis	1.02e-05	0.000305	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—BMP2—osteoporosis	1.02e-05	0.000305	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—ACP5—osteoporosis	1.02e-05	0.000305	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—TPI1—osteoporosis	1.02e-05	0.000304	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.01e-05	0.000301	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—ENO1—osteoporosis	1e-05	0.000299	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—FGB—osteoporosis	9.99e-06	0.000299	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	9.96e-06	0.000298	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CALCA—osteoporosis	9.92e-06	0.000297	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—CYP19A1—osteoporosis	9.91e-06	0.000296	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PSMA2—osteoporosis	9.85e-06	0.000295	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PSMA5—osteoporosis	9.85e-06	0.000295	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—ENO1—osteoporosis	9.8e-06	0.000293	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—P4HB—osteoporosis	9.78e-06	0.000292	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—ENO1—osteoporosis	9.78e-06	0.000292	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—POMC—osteoporosis	9.68e-06	0.000289	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PSMA2—osteoporosis	9.65e-06	0.000289	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PSMA5—osteoporosis	9.65e-06	0.000289	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PSMA2—osteoporosis	9.64e-06	0.000288	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PSMA5—osteoporosis	9.64e-06	0.000288	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PSMA2—osteoporosis	9.63e-06	0.000288	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PSMA5—osteoporosis	9.63e-06	0.000288	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—GAPDH—osteoporosis	9.6e-06	0.000287	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—TPI1—osteoporosis	9.57e-06	0.000286	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—P4HB—osteoporosis	9.55e-06	0.000285	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—IDH2—osteoporosis	9.53e-06	0.000285	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—TPI1—osteoporosis	9.48e-06	0.000284	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—GAPDH—osteoporosis	9.37e-06	0.00028	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—RAP1A—osteoporosis	9.35e-06	0.00028	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—ENO1—osteoporosis	9.24e-06	0.000276	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	9.13e-06	0.000273	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—RAP1A—osteoporosis	9.13e-06	0.000273	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PSMA2—osteoporosis	9.1e-06	0.000272	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PSMA5—osteoporosis	9.1e-06	0.000272	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—KL—osteoporosis	9.01e-06	0.000269	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—P4HB—osteoporosis	8.99e-06	0.000269	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CALCA—osteoporosis	8.98e-06	0.000269	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CYP27A1—osteoporosis	8.96e-06	0.000268	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—P4HB—osteoporosis	8.92e-06	0.000267	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CA2—osteoporosis	8.88e-06	0.000265	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—OXCT1—osteoporosis	8.88e-06	0.000265	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—GAPDH—osteoporosis	8.83e-06	0.000264	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—POMC—osteoporosis	8.79e-06	0.000263	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—POMC—osteoporosis	8.76e-06	0.000262	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—GAPDH—osteoporosis	8.75e-06	0.000262	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—ACP5—osteoporosis	8.72e-06	0.000261	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—MGLL—osteoporosis	8.65e-06	0.000259	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	8.61e-06	0.000257	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—RAP1A—osteoporosis	8.6e-06	0.000257	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—IL6R—osteoporosis	8.57e-06	0.000256	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—RAP1A—osteoporosis	8.52e-06	0.000255	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—ENO1—osteoporosis	8.47e-06	0.000253	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PSMA2—osteoporosis	8.34e-06	0.000249	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PSMA5—osteoporosis	8.34e-06	0.000249	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—MYC—osteoporosis	8.22e-06	0.000246	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—TGFB1—osteoporosis	8.21e-06	0.000245	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—KL—osteoporosis	8.16e-06	0.000244	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	8.15e-06	0.000244	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—TPI1—osteoporosis	8.1e-06	0.000242	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—ADCY5—osteoporosis	8.1e-06	0.000242	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—GPX1—osteoporosis	8.07e-06	0.000241	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—CYP19A1—osteoporosis	8e-06	0.000239	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—POMC—osteoporosis	7.96e-06	0.000238	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—CYP19A1—osteoporosis	7.83e-06	0.000234	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—CYP19A1—osteoporosis	7.81e-06	0.000234	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—IL6R—osteoporosis	7.76e-06	0.000232	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—P4HB—osteoporosis	7.62e-06	0.000228	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—ENO1—osteoporosis	7.56e-06	0.000226	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—GAPDH—osteoporosis	7.48e-06	0.000224	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PSMA5—osteoporosis	7.45e-06	0.000223	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PSMA2—osteoporosis	7.45e-06	0.000223	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—MTHFR—osteoporosis	7.45e-06	0.000223	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	7.43e-06	0.000222	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—CYP19A1—osteoporosis	7.38e-06	0.000221	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—ENO1—osteoporosis	7.38e-06	0.000221	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—IDH2—osteoporosis	7.36e-06	0.00022	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—RAP1A—osteoporosis	7.28e-06	0.000218	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PSMA2—osteoporosis	7.27e-06	0.000217	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PSMA5—osteoporosis	7.27e-06	0.000217	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—ADCY5—osteoporosis	7.06e-06	0.000211	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—ENO1—osteoporosis	6.95e-06	0.000208	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CYP27A1—osteoporosis	6.92e-06	0.000207	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—ENO1—osteoporosis	6.89e-06	0.000206	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PSMA2—osteoporosis	6.85e-06	0.000205	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PSMA5—osteoporosis	6.85e-06	0.000205	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—SPP1—osteoporosis	6.83e-06	0.000204	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PSMA2—osteoporosis	6.79e-06	0.000203	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PSMA5—osteoporosis	6.79e-06	0.000203	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—CYP19A1—osteoporosis	6.77e-06	0.000202	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ACP5—osteoporosis	6.73e-06	0.000201	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—ADCY5—osteoporosis	6.53e-06	0.000195	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—GPX1—osteoporosis	6.51e-06	0.000195	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—ADCY5—osteoporosis	6.4e-06	0.000191	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—ADCY5—osteoporosis	6.39e-06	0.000191	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—ADCY5—osteoporosis	6.39e-06	0.000191	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—GPX1—osteoporosis	6.38e-06	0.000191	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—GPX1—osteoporosis	6.36e-06	0.00019	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	6.35e-06	0.00019	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—TPI1—osteoporosis	6.25e-06	0.000187	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—IL6—osteoporosis	6.18e-06	0.000185	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—SPP1—osteoporosis	6.18e-06	0.000185	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—IRS2—osteoporosis	6.18e-06	0.000185	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—LEP—osteoporosis	6.04e-06	0.000181	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—CYP19A1—osteoporosis	6.04e-06	0.000181	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—ADCY5—osteoporosis	6.03e-06	0.00018	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—GPX1—osteoporosis	6.01e-06	0.00018	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—MTHFR—osteoporosis	6.01e-06	0.00018	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—POMC—osteoporosis	5.96e-06	0.000178	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—CYP19A1—osteoporosis	5.9e-06	0.000176	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—ENO1—osteoporosis	5.89e-06	0.000176	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—MTHFR—osteoporosis	5.88e-06	0.000176	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—P4HB—osteoporosis	5.88e-06	0.000176	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—MTHFR—osteoporosis	5.87e-06	0.000176	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PSMA2—osteoporosis	5.8e-06	0.000174	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PSMA5—osteoporosis	5.8e-06	0.000174	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—GAPDH—osteoporosis	5.77e-06	0.000173	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—ESR1—osteoporosis	5.77e-06	0.000173	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—RAP1A—osteoporosis	5.62e-06	0.000168	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IRS2—osteoporosis	5.59e-06	0.000167	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—CYP19A1—osteoporosis	5.56e-06	0.000166	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—MTHFR—osteoporosis	5.55e-06	0.000166	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—ADCY5—osteoporosis	5.53e-06	0.000165	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—GPX1—osteoporosis	5.51e-06	0.000165	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CYP19A1—osteoporosis	5.51e-06	0.000165	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—LEP—osteoporosis	5.47e-06	0.000164	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—IRS1—osteoporosis	5.39e-06	0.000161	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—ESR1—osteoporosis	5.22e-06	0.000156	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—POMC—osteoporosis	5.19e-06	0.000155	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—MTHFR—osteoporosis	5.09e-06	0.000152	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—IL6R—osteoporosis	5.07e-06	0.000151	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—IGF1—osteoporosis	4.99e-06	0.000149	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—ADCY5—osteoporosis	4.94e-06	0.000148	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—GPX1—osteoporosis	4.92e-06	0.000147	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IRS1—osteoporosis	4.88e-06	0.000146	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—ADCY5—osteoporosis	4.82e-06	0.000144	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—POMC—osteoporosis	4.81e-06	0.000144	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—GPX1—osteoporosis	4.8e-06	0.000144	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CYP19A1—osteoporosis	4.71e-06	0.000141	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—POMC—osteoporosis	4.71e-06	0.000141	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—POMC—osteoporosis	4.7e-06	0.000141	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—POMC—osteoporosis	4.7e-06	0.00014	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IL6R—osteoporosis	4.59e-06	0.000137	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ENO1—osteoporosis	4.54e-06	0.000136	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—ADCY5—osteoporosis	4.54e-06	0.000136	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—MTHFR—osteoporosis	4.54e-06	0.000136	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—GPX1—osteoporosis	4.52e-06	0.000135	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IGF1—osteoporosis	4.52e-06	0.000135	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—ADCY5—osteoporosis	4.5e-06	0.000135	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—GPX1—osteoporosis	4.49e-06	0.000134	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PSMA2—osteoporosis	4.48e-06	0.000134	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PSMA5—osteoporosis	4.48e-06	0.000134	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—POMC—osteoporosis	4.44e-06	0.000133	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—MTHFR—osteoporosis	4.43e-06	0.000133	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—MTHFR—osteoporosis	4.18e-06	0.000125	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—MTHFR—osteoporosis	4.14e-06	0.000124	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—POMC—osteoporosis	4.07e-06	0.000122	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—ADCY5—osteoporosis	3.85e-06	0.000115	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—GPX1—osteoporosis	3.83e-06	0.000115	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—IL6—osteoporosis	3.82e-06	0.000114	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CYP19A1—osteoporosis	3.63e-06	0.000109	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—POMC—osteoporosis	3.63e-06	0.000109	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—POMC—osteoporosis	3.54e-06	0.000106	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—MTHFR—osteoporosis	3.54e-06	0.000106	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—IL6—osteoporosis	3.46e-06	0.000103	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—POMC—osteoporosis	3.34e-06	9.99e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—POMC—osteoporosis	3.31e-06	9.9e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MYC—osteoporosis	3e-06	8.98e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—TGFB1—osteoporosis	2.99e-06	8.95e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ADCY5—osteoporosis	2.97e-06	8.88e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—GPX1—osteoporosis	2.96e-06	8.85e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—POMC—osteoporosis	2.83e-06	8.46e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—MTHFR—osteoporosis	2.73e-06	8.16e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MYC—osteoporosis	2.72e-06	8.13e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—TGFB1—osteoporosis	2.71e-06	8.11e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—IL6—osteoporosis	2.26e-06	6.75e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—POMC—osteoporosis	2.18e-06	6.53e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IL6—osteoporosis	2.04e-06	6.11e-05	CbGpPWpGaD
